On November 21, 2025, AnaptysBio, Inc. announced an increase to its Stock Repurchase Plan, adding $100 million to the $75 million plan, with $6.4 million still available from the previous authorization. The company has already repurchased 3,443,188 shares, representing 11.2% of its outstanding shares before the plan started.